Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer

Liquid biopsy (LB) is a useful tool in patients with advanced non-small cell lung cancer (aNSCLC) to detect actionable molecular alterations and thereby allow genotype-matched therapies. Currently, LB is recommended for individuals diagnosed with aNSCLC who have an insufficient tissue sample or diff...

Full description

Bibliographic Details

Main Authors:	Emma Holjak, Tia Brasoveanu, Saurav Verma, Saqib Khan, Morgan Black, Inderdeep Dhaliwal, Michael Mitchell, Rahul Nayak, Mehdi Qiabi, Richard Inculet, Dalilah Fortin, Richard Malthaner, Matthew Cecchini, Anna Lapuk, Daniel Breadner
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2025-12-01
Series:	The Journal of Liquid Biopsy
Subjects:	Liquid biopsy NSCLC ctDNA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950195425001596
Tags:	Add Tag No Tags, Be the first to tag this record!